WHO SNAKE-BITE MANAGEMENT - Antivenom (AV) therapy and supportive care
   
(adapted to: Warrell DA, WHO guidelines for physicians 2010)

    AV should be given only to patients in whom its benefits are considered likely to
    exceed its risks.

Indications for AV therapy

AV is indicated:

1) Systemic envenoming (one or several of the following):

  • Haemostatic abnormalities: spontaneous systemic bleeding, coagulopathy, thrombocytopenia (<100x109/litre)
  • Cardiovascular abnormalities: hypotension, shock, cardiac arrhythmia, abnormal ECG
  • Acute kidney injury: oliguria/anuria, rising blood creatinine/urea
  • Haemoglobin-/Myoglobinuria
  • Neurotoxic signs: ptosis, external ophthalmoplegia, paralysis etc.

2) Local envenoming (one or several of the following):

  • Swelling involving more than half of the bitten limb within 48 hours after bite
  • Severe swelling after bites on digits (fingers or toes)
  • Rapid extension of swelling, beyond wrist or ankle within a few hours after bite
  • Development of an enlarged tender lymph node draining the bitten limb

When indicated, AV should be given as early as possible, and in case of coagulopathy, as long as coagulopathy exists.

Adverse reactions of patients to AV, and treatment

Adverse reactions to AV typically in >10% of patients

  • Anaphylactic reaction (rare!): usually within 3 hours after AV administration
  • Pyrogenic (endotoxin) reactions (common): usually within 2 hours

Treatment for both: adrenalin (0.1% solution, 1:1000, 1 mg/ml), 0.5 mg for adults, 0.01 mg/kg for children; intramuscularly into upper lateral thigh; repeat dose every 5-10 min if patient’s condition deteriorates. In addition: antihistamines (chlorphenamine maleate, adults: 10 mg, children: 0.2 mg/kg i.v.; hydrocortisone, adults: 100 mg, children: 2 mg/kg i.v. In pyrogenic reactions: paracetamol per os to reduce fever. In all cases: i.v. fluids to correct hypovolemia.

  • Late (serum sickness type) reactions: usually within 7 days

Treatment: Oral anithistamines: chlorphenamine, adults: 2 mg hourly, children: 0.25 mg/kg/day in 5-7 doses; or: prednisolone, adults: 5 mg six-hourly, children: 0.7 mg/kg/day in 5-7 doses.

Administration of AV

Have adrenalin ready before AV administration

  • Initial (mono- or polyvalent) AV dose: see Manufacturer’s recommendation
  • If necessary, reconstitute lyophilized (freeze-dried) AV in 10 ml sterile water (swirl, do not shake)
  • i.v. inject AV at 2 ml/minute; alternatively, dilute AV in isotonic saline (5-10 ml/kg body weight) and i.v.-infuse over 1 hour period; DO NOT administer AV locally
  • Monitor patient for > 1 hour after starting AV treatment for early anaphylactic signs

AV must be given until symptoms resolve; if necessary at 1-2 hour intervals, for coagulopathy at 6 hour intervals. Bleeding stops within 15-30 minutes; coagulopathy within 3-9 hours; blood pressure

back to normal within 60 minutes; neurotoxicity resolves within 30 min to several hours, haemolysis and rhabdomyolysis within a few hours.

All patients have to be monitored for at least 48 hours.

Treatment when no AV is available, and medical support of AV therapy

1) Neurotoxic envenoming:

  • Maintenance of clear airway; assisted ventilation; mechanical ventilation: (required typically from 30 min to 24 hours (mean: 4-7 hours) after a severe neurotoxic bite, for the duration of 24 hours to several days, rarely longer)
  • Anticholinesterase treatment should be tried in every patient with neurotoxic envenoming. It may or may not be effective. i.v.-inject atropine sulphate (0.6 mg for adults, 0.05 mg/kg for children), then i.m.-inject neostigmine or prostigmine (0.02 mg/kg for adults, 0.04 mg/kg for children).

2) Hypotension and shock:

  • Give plasma expanders (colloids or crystalloids) and monitor central venous pressure. Beware of pulmonary oedema.
  • Generally increased capillary permeability: i.v.-infuse dopamine (2.5-5.0 micrograms/kg/minute)

3) Oliguria and acute kidney injury (urine output <20 ml/hour):

  • In case of hypovolemia: infuse 2 litres of isotonic saline over one hour. Beware of pulmonary oedema. Catheterize patient, inject 100 mg furosemide over 20 minutes, monitor serum potassium, urea, creatinine, pH, bicarbonate, calcium and phosphate frequently
  • In case of hyperkalaemia: give, up to three times, 10 ml of 10% calcium gluconate over 2 minutes, and 50 ml of 50% dextrose with 10 units of soluble insulin, and 40 ml of 8.4% sodium bicarbonate by slow i.v. infusion
  • In case of severe acidosis: give 40 ml of 8.4% sodium bicarbonate in 5% dextrose water over 3-4 hours

If no clinical improvement is achieved: dialysis

Dialysis is also indicated in case of: clinical uraemia, fluid overload, creatinine >4 mg/dl (500 micromol/litre), urea >130 mg/dl (27 mmol/litre), potassium >7mmol/litre and symptomatic acidosis

  • In case of rhabdomyolysis or haemolysis: maintain saline diuresis (if possible), correct severe acidosis with bicarbonate
  • Beware of the diuretic phase of kidney injury (following oliguric phase): correct hypokalaemia with potassium (fruit juice) if necessary; if long lasting (up to several months): replace corticosteroids, fluid and electrolytes

4) Haemostatic disturbances:

DO NOT use heparin or antifibrinolytic agents

In patients with coagulopathy, placement of venipuncture (if necessary) should be chosen where haemostasis by external pressure is most likely to be effective (e.g., antecubital fossa)

Treatment of bitten part: aspirate bullae only when rupture seems likely. Control secondary infection by single dose of amoxycillin and tetanus prophylaxis

Compartment syndrome: intracompartmental pressure of >40 mm Hg (less in children): if possible, fasciotomy should be delayed until haemostatic disturbances have been corrected.

Therapierichtlinien der Weltgesundheitsorganisation (WHO)

Serum ausschließlich im Notfall, und nur, wenn ein Profit für den Patienten zu erwarten ist.

WHO SNAKE-BITE MANAGEMENT - Antivenom (AV) therapy and supportive care
(adapted to: Warrell DA, WHO guidelines for physicians 2010)

Indications for AV therapy

AV is indicated:

1) Systemic envenoming (one or several of the following):

  • Haemostatic abnormalities: spontaneous systemic bleeding, coagulopathy, thrombocytopenia (<100x109/litre)
  • Cardiovascular abnormalities: hypotension, shock, cardiac arrhythmia, abnormal ECG
  • Acute kidney injury: oliguria/anuria, rising blood creatinine/urea
  • Haemoglobin-/Myoglobinuria
  • Neurotoxic signs: ptosis, external ophthalmoplegia, paralysis etc.

2) Local envenoming (one or several of the following):

  • Swelling involving more than half of the bitten limb within 48 hours after bite
  • Severe swelling after bites on digits (fingers or toes)
  • Rapid extension of swelling, beyond wrist or ankle within a few hours after bite
  • Development of an enlarged tender lymph node draining the bitten limb

When indicated, AV should be given as early as possible, and in case of coagulopathy, as long as coagulopathy exists.

Adverse reactions of patients to AV, and treatment

Adverse reactions to AV typically in >10% of patients

  • Anaphylactic reaction (rare!): usually within 3 hours after AV administration
  • Pyrogenic (endotoxin) reactions (common): usually within 2 hours

Treatment for both: adrenalin (0.1% solution, 1:1000, 1 mg/ml), 0.5 mg for adults, 0.01 mg/kg for children; intramuscularly into upper lateral thigh; repeat dose every 5-10 min if patient’s condition deteriorates. In addition: antihistamines (chlorphenamine maleate, adults: 10 mg, children: 0.2 mg/kg i.v.; hydrocortisone, adults: 100 mg, children: 2 mg/kg i.v. In pyrogenic reactions: paracetamol per os to reduce fever. In all cases: i.v. fluids to correct hypovolemia.

  • Late (serum sickness type) reactions: usually within 7 days

Treatment: Oral anithistamines: chlorphenamine, adults: 2 mg hourly, children: 0.25 mg/kg/day in 5-7 doses; or: prednisolone, adults: 5 mg six-hourly, children: 0.7 mg/kg/day in 5-7 doses.

Administration of AV

Have adrenalin ready before AV administration

  • Initial (mono- or polyvalent) AV dose: see Manufacturer’s recommendation
  • If necessary, reconstitute lyophilized (freeze-dried) AV in 10 ml sterile water (swirl, do not shake)
  • i.v. inject AV at 2 ml/minute; alternatively, dilute AV in isotonic saline (5-10 ml/kg body weight) and i.v.-infuse over 1 hour period; DO NOT administer AV locally
  • Monitor patient for > 1 hour after starting AV treatment for early anaphylactic signs

AV must be given until symptoms resolve; if necessary at 1-2 hour intervals, for coagulopathy at 6 hour intervals. Bleeding stops within 15-30 minutes; coagulopathy within 3-9 hours; blood pressure

back to normal within 60 minutes; neurotoxicity resolves within 30 min to several hours, haemolysis and rhabdomyolysis within a few hours.

All patients have to be monitored for at least 48 hours.

Treatment when no AV is available, and medical support of AV therapy

1) Neurotoxic envenoming:

  • Maintenance of clear airway; assisted ventilation; mechanical ventilation: (required typically from 30 min to 24 hours (mean: 4-7 hours) after a severe neurotoxic bite, for the duration of 24 hours to several days, rarely longer)
  • Anticholinesterase treatment should be tried in every patient with neurotoxic envenoming. It may or may not be effective. i.v.-inject atropine sulphate (0.6 mg for adults, 0.05 mg/kg for children), then i.m.-inject neostigmine or prostigmine (0.02 mg/kg for adults, 0.04 mg/kg for children).

2) Hypotension and shock:

  • Give plasma expanders (colloids or crystalloids) and monitor central venous pressure. Beware of pulmonary oedema.
  • Generally increased capillary permeability: i.v.-infuse dopamine (2.5-5.0 micrograms/kg/minute)

3) Oliguria and acute kidney injury (urine output <20 ml/hour):

  • In case of hypovolemia: infuse 2 litres of isotonic saline over one hour. Beware of pulmonary oedema. Catheterize patient, inject 100 mg furosemide over 20 minutes, monitor serum potassium, urea, creatinine, pH, bicarbonate, calcium and phosphate frequently
  • In case of hyperkalaemia: give, up to three times, 10 ml of 10% calcium gluconate over 2 minutes, and 50 ml of 50% dextrose with 10 units of soluble insulin, and 40 ml of 8.4% sodium bicarbonate by slow i.v. infusion
  • In case of severe acidosis: give 40 ml of 8.4% sodium bicarbonate in 5% dextrose water over 3-4 hours

If no clinical improvement is achieved: dialysis

Dialysis is also indicated in case of: clinical uraemia, fluid overload, creatinine >4 mg/dl (500 micromol/litre), urea >130 mg/dl (27 mmol/litre), potassium >7mmol/litre and symptomatic acidosis

  • In case of rhabdomyolysis or haemolysis: maintain saline diuresis (if possible), correct severe acidosis with bicarbonate
  • Beware of the diuretic phase of kidney injury (following oliguric phase): correct hypokalaemia with potassium (fruit juice) if necessary; if long lasting (up to several months): replace corticosteroids, fluid and electrolytes

4) Haemostatic disturbances:

DO NOT use heparin or antifibrinolytic agents

In patients with coagulopathy, placement of venipuncture (if necessary) should be chosen where haemostasis by external pressure is most likely to be effective (e.g., antecubital fossa)

Treatment of bitten part: aspirate bullae only when rupture seems likely. Control secondary infection by single dose of amoxycillin and tetanus prophylaxis

Compartment syndrome: intracompartmental pressure of >40 mm Hg (less in children): if possible, fasciotomy should be delayed until haemostatic disturbances have been corrected.

Zum Vergrößern bitte auf das jeweilige Foto klicken

DGINA, Kassel, 2021
DGINA, Kassel, 2021
Notfälle in der Gastroenterologie, Medizinische Hochschule Hannover, 2022
MHH1       
 


 

 

Referenzen für Mediziner und Rettungskräfte    
Weitere Referenzen und Links: Siehe unten auf dieser Seite                     

Der direkte Weg zur medizinischen Hilfe
und zum Serum für Ärzte
bei einem Giftschlangenbiss in 3 Schritten

 Unbedingte Voraussetzung zur Hilfe:
   
    Wir benötigen zwingend den lateinischen Artnamen der Schlange, die den Patienten
    gebissen hat. Pauschale Aussagen wie Biss von einer "Kobra" oder "Klapperschlange"
    sind alles andere als zielführend und sehr gefährlich.
    Unsere Erfahrungen der letzten 15 Jahre besagen, dass 99,9 % der Gebissenen
    genau wissen, von welcher Giftschlange der Biss erfolgte.
    Bitte fragen Sie ggf. den erstversorgenden Notarzt.

1) Setzen Sie sich mit unserem 24/7 besetzten Notruf in Verbindung:

+49 30 - 5444 5989

    Wir ermitteln, welches Serum geeignet ist (sofern überhaupt ein Serum produziert
    wird), welches Depot nächstgelegen zu Ihnen ist und welche Serenmenge Sie
    benötigen.

2) Serenabruf

    Hinweis: Sie benötigen ein Telefaxgerät.

    Sie erhalten von unseren Notrufmitarbeitern die Kontaktdaten des Depots. Alle Depots
    befinden sich in Krankenhausapotheken, die ebenfalls 24/7 besetzt sind.
Das Depot,
    das ihnen vom Berater genannt wurde, schickt Ihnen ein vorausgefülltes Telefax mit
    den Serumangaben

oder

    Sie tragen das Serum, das Ihnen vom Berater benannt wurde, in das von Ihnen selbst
    heruntergeladene und ausgedruckte Exemplar ein und schicken es ausgefüllt
    (Telefaxnummer im Formular) mit den vollständigen Angaben:

  • zu Ihrem Krankenhaus (Adresse, Telefon- und Telefaxnummer),

  • des anfordernden Arztes bzw. Apothekers (Name und unter welcher Telefonnummer
    erreichbar) und

  • den Patientendaten (Name, Adresse, *Geburtsdatum, Patientenaufnahmenummer,
    am besten als Patientenaufkleber)

      an das vom Berater benannte Depot, damit die Serumherausgabe und der Serenver-
      bleib vom herausgebenden Depot vernünftig dokumentiert werden kann.

      Die obigen Angaben sind essentiell für eine Bestellung. Ohne Ross und Reiter zu
      nennen ist keine Bestellung möglich!

3) Medizinische Hilfestellungen

    Hinweis: Sie benötigen ggf. eine Mailadresse.

    a) (Erst-)Behandlungshinweise

        Wir verfügen über eine eigene Datenbank mit sehr umfangreichen Behandlungs-
        hinweisen und haben ebenso Zugriff auf die Datenbank des Klinikums rechts der
        Isar / Technische Universität, München.
        Diese Informationen können wir Ihnen gezielt per Mail zur Verfügung stellen.

    b) Beipackzettel des Serenherstellers

        Zu allen Seren, die verfügbar sind, können wir Ihnen vorab die sog. Beipackzettel
        per Mail zur Verfügung stellen, die weitere Hinweise zur Bissbehandlung enthalten.
        Diese sind allerdings meist sehr allgemein gehalten.

    c) Kontaktvermittlung

        Wir können Ihnen einen persönlichen Kontakt zu einem Arzt oder einer medizinisch
        sehr erfahrenen Person vermitteln, die über erhebliche Erfahrung in der Behandlung
        von Giftschlangenbissen verfügt.

Weitere Referenzen, Links und Downloads:

AV should be given only to patients in whom its benefits are considered likely to exceed its risks - WHO - Indications for AV therapy
(Kurzform, Englisch)
 
Diese Beschreibung
Musterformular Serenanforderung
WHO Guidelines zur Behandlung vom Giftschlangenbissen

Studie der University of California zur Wirksamkeit von Seren nach Herstellerverfallsdatum (Englisch)

Diese Studie stellen wir gerne bei Bedarf dem behandelnden Arzt zur Verfügung. Bitte rufen Sie uns an.

 

Wir nutzen Cookies auf unserer Website. Einige von ihnen sind essenziell für den Betrieb der Seite, während andere uns helfen, diese Website und die Nutzererfahrung zu verbessern (Tracking Cookies). Sie können selbst entscheiden, ob Sie die Cookies zulassen möchten. Bitte beachten Sie, dass bei einer Ablehnung womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen.